Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RG 6146

Next Previous
X
Search
Drug Profile

RG 6146

Alternative Names: RG6146; RO 6870810; TEN 010

Latest Information Update: 02 Jun 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Tensha Therapeutics
  • Developer Roche
  • Class Antineoplastics; Small molecules
  • Mechanism of Action Bromodomain and extraterminal domain protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Acute myeloid leukaemia; Diffuse large B cell lymphoma; Multiple myeloma; Myelodysplastic syndromes; Ovarian cancer; Solid tumours; Triple negative breast cancer

Most Recent Events

  • 10 Apr 2021 Efficacy and adverse events data from a phase I trial in Ovarian cancer and Breast cancer presented at the 112th Annual Meeting of the American Association for Cancer Research (AACR-2021)
  • 05 Dec 2020 Efficacy, pharmacokinetics and adverse events data from a phase I trial in Multile myeloma presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology (ASH-2020)
  • 16 Oct 2019 Discontinued - Phase-I for Multiple myeloma (Combination therapy, In the elderly, Late-stage disease, Second-line therapy or greater, In adults) in United Kingdom, after October 2019 (SC) (NCT03068351)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top